Cargando…
Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats
Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating, treatment-limiting, side-effect of several classes of chemotherapy drugs. While negatively impacting oncology patients’ quality of life, chemotherapy-induced large-fiber (LF) neuropathy is amongst the least well understood componen...
Autores principales: | Mansooralavi, Niloufar, Khomula, Eugen V, Levine, Jon D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288414/ https://www.ncbi.nlm.nih.gov/pubmed/37338165 http://dx.doi.org/10.1177/17448069231185694 |
Ejemplares similares
-
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013) -
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
por: Canta, Annalisa, et al.
Publicado: (2015) -
Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
por: Sansone, Pasquale, et al.
Publicado: (2022) -
An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN
por: Holloway, Michael P, et al.
Publicado: (2016) -
Prevention and Treatment for Chemotherapy-Induced Peripheral
Neuropathy: Therapies Based on CIPN Mechanisms
por: Hu, Lang-Yue, et al.
Publicado: (2019)